Patient and Caregiver Burden in the Home-Infusion Era

This segment examines the burdens that persist even within a well-designed transition pathway. On the patient side, faculty highlight limited mobility from refractory joint involvement, the frequent need for central venous access and its associated infection risk, and the challenge of ensuring patients actually reach and adhere to treatment after leaving the center. Insurance lag during transition can delay therapy and create real emotional distress for patients and families. Faculty then weigh the caregiver experience, which cuts both ways: home infusion can reduce stress and restore a sense of normalcy, yet it can also shift substantial monitoring and day-to-day responsibility onto family members. Balanced against these burdens is the central advantage of home infusion, the flexibility that lets patients reclaim work, family, and daily life. Faculty are candid about the trade-offs, including lost face-to-face contact, missed subtle symptom changes, patient under-reporting, and the heightened coordination such transitions demand.